INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,563 | +25.0% | 3,126 | +137.9% | 0.00% | – |
| Q4 2022 | $2,050 | -48.8% | 1,314 | -32.6% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 1,950 | -20.9% | 0.00% | – |
| Q2 2022 | $4,000 | +100.0% | 2,466 | +328.9% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 575 | +2111.5% | 0.00% | – |
| Q3 2020 | $1,000 | -100.0% | 26 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $2,633,000 | +131550.0% | 97,696 | +45129.6% | 0.01% | – |
| Q1 2020 | $2,000 | 0.0% | 216 | -72.1% | 0.00% | – |
| Q3 2019 | $2,000 | -83.3% | 775 | -81.4% | 0.00% | – |
| Q2 2019 | $12,000 | -25.0% | 4,166 | 0.0% | 0.00% | – |
| Q1 2019 | $16,000 | -96.4% | 4,166 | -96.2% | 0.00% | -100.0% |
| Q4 2018 | $440,000 | +4788.9% | 109,898 | +6755.8% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 1,603 | -12.5% | 0.00% | – |
| Q4 2017 | $8,000 | -33.3% | 1,833 | -2.6% | 0.00% | – |
| Q3 2017 | $12,000 | – | 1,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |